RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE

AroCell AB (publ) Equity 2024

AroCell AB (publ) Equity

163.65 M SEK

AroCell AB (publ) Dividend yield

Ticker

AROC.ST

ISIN

SE0003883990

WKN

A12CNW

In 2024, AroCell AB (publ)'s equity was 163.65 M SEK, a -26.52% increase from the 222.69 M SEK equity in the previous year.

AroCell AB (publ) Aktienanalyse

What does AroCell AB (publ) do?

AroCell AB (publ) ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Equity Details

Analyzing AroCell AB (publ)'s Equity

AroCell AB (publ)'s equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding AroCell AB (publ)'s equity is essential for assessing its financial health, stability, and value to shareholders.

Year-to-Year Comparison

Evaluating AroCell AB (publ)'s equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.

Impact on Investments

AroCell AB (publ)'s equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.

Interpreting Equity Fluctuations

Fluctuations in AroCell AB (publ)’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.

Frequently Asked Questions about AroCell AB (publ) Stock

What is the equity of AroCell AB (publ) this year?

AroCell AB (publ) has equity of 163.65 M SEK this year.

What was the equity of AroCell AB (publ) compared to the previous year?

The equity of AroCell AB (publ) has increased/decreased by -26.52% decreased compared to the previous year.

What impact does a high equity have on investors of AroCell AB (publ)?

A high equity is advantageous for investors of AroCell AB (publ) as it is an indicator of the company's financial stability and its ability to manage risks and challenges.

What impact does low equity have on investors of AroCell AB (publ)?

A low equity can be a risk for investors of AroCell AB (publ), as it can put the company in a weaker financial position and impair its ability to manage risks and challenges.

How does an increase in equity of AroCell AB (publ) affect the company?

An increase in equity of AroCell AB (publ) can strengthen the company's financial position and improve its ability to make investments in the future.

How does a reduction in the equity of AroCell AB (publ) affect the company?

A reduction in equity of AroCell AB (publ) can affect the financial situation of the company and lead to a higher dependence on debt capital.

What are some factors that influence the equity of AroCell AB (publ)?

Some factors that can affect the equity of AroCell AB (publ) include profits, dividend payments, capital increases, and acquisitions.

Why is the equity of AroCell AB (publ) so important for investors?

The equity of AroCell AB (publ) is important for investors as it is an indicator of the financial strength of the company and can be an indication of how well the company is able to fulfill its financial obligations.

What strategic measures can AroCell AB (publ) take to change the equity?

To change equity, AroCell AB (publ) can take various measures such as increasing profits, conducting capital increases, reducing expenses, and acquiring companies. It is important for the company to perform a thorough review of its financial situation to determine the best strategic actions to modify its equity.

How much dividend does AroCell AB (publ) pay?

Over the past 12 months, AroCell AB (publ) paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, AroCell AB (publ) is expected to pay a dividend of 0 SEK.

What is the dividend yield of AroCell AB (publ)?

The current dividend yield of AroCell AB (publ) is .

When does AroCell AB (publ) pay dividends?

AroCell AB (publ) pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of AroCell AB (publ)?

AroCell AB (publ) paid dividends every year for the past 0 years.

What is the dividend of AroCell AB (publ)?

For the upcoming 12 months, dividends amounting to 0 SEK are expected. This corresponds to a dividend yield of 0 %.

In which sector is AroCell AB (publ) located?

AroCell AB (publ) is assigned to the 'Health' sector.

Wann musste ich die Aktien von AroCell AB (publ) kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of AroCell AB (publ) from 5/16/2024 amounting to 0 SEK, you needed to have the stock in your portfolio before the ex-date on 5/16/2024.

When did AroCell AB (publ) pay the last dividend?

The last dividend was paid out on 5/16/2024.

What was the dividend of AroCell AB (publ) in the year 2023?

In the year 2023, AroCell AB (publ) distributed 0 SEK as dividends.

In which currency does AroCell AB (publ) pay out the dividend?

The dividends of AroCell AB (publ) are distributed in SEK.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von AroCell AB (publ)

Our stock analysis for AroCell AB (publ) Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of AroCell AB (publ) Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.